RAM
GMAB icon

Riggs Asset Management’s Genmab GMAB Stock Holding History

Riggs Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-50
Closed -$1.03K – 405
2025
Q2 		$1.03K Hold
50
– – ﹤0.01% 759
2025
Q1 		$979 Hold
50
– – ﹤0.01% 494
2024
Q4 		$1.04K Hold
50
– – ﹤0.01% 451
2024
Q3 		$1.22K Hold
50
– – ﹤0.01% 418
2024
Q2 		$1.26K Hold
50
– – ﹤0.01% 409
2024
Q1 		$1.5K Hold
50
– – ﹤0.01% 380
2023
Q4 		$1.59K Hold
50
– – ﹤0.01% 348
2023
Q3 		$1.76K Buy
+50
New +$1.91K ﹤0.01% 353

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Riggs Asset Management's GMAB Position: Q3 2025 in Review

Riggs Asset Management sold out of Genmab (GMAB) in Q3 2025, closing a stake of 50 shares — an estimated $1.03K sold.

Riggs Asset Management first reported a position in GMAB in Q3 2023 and held it in 8 quarters. The position peaked at $1.76K in Q3 2023. 252 funds tracked by Wall St. Rank hold GMAB as of Q3 2025.

  • Riggs Asset Management reported no remaining Genmab position as of Q3 2025 after selling out during the quarter.
  • Riggs Asset Management sold 50 Genmab shares in Q3 2025, an estimated $1.03K.
  • Riggs Asset Management first reported a position in Genmab in Q3 2023 and held it in 8 quarters.
  • Riggs Asset Management's Genmab position peaked at $1.76K in Q3 2023.
  • 252 funds tracked by Wall St. Rank held Genmab as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.